Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to AVM BIOTECHNOLOGY, LLC in July, 2020 for $224,770.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA246896-01A1 | Phase I | 224,770 | July 1, 2020 | |||||||
A SBIR Phase II contract was awarded to AVM BIOTECHNOLOGY, LLC in June, 2022 for $999,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA272096-01 | Phase II | 999,999 | June 10, 2022 | |||||||
A SBIR Phase I contract was awarded to AVM BIOTECHNOLOGY, LLC in September, 2019 for $211,047.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK121634-01A1 | Phase I | 211,047 | September 20, 2019 | |||||||
A SBIR Phase II contract was awarded to AVM BIOTECHNOLOGY, LLC in April, 2022 for $667,733.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK121634-02A1 | Phase II | 667,733 | April 1, 2022 | |||||||
A SBIR Phase I contract was awarded to AVM BIOTECHNOLOGY, LLC in August, 2022 for $399,193.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA271951-01A1 | Phase I | 399,193 | August 5, 2022 |